Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00854945
First received: March 2, 2009
Last updated: May 5, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)